252 related articles for article (PubMed ID: 7518353)
21. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
22. MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells.
Lutz W; Fulda S; Jeremias I; Debatin KM; Schwab M
Oncogene; 1998 Jul; 17(3):339-46. PubMed ID: 9690515
[TBL] [Abstract][Full Text] [Related]
23. Role of CD44H carbohydrate structure in neuroblastoma adhesive properties.
Gross N; Balmas K; Beretta Brognara C
Med Pediatr Oncol; 2001 Jan; 36(1):139-41. PubMed ID: 11464867
[TBL] [Abstract][Full Text] [Related]
24. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
25. MYCN downregulates integrin alpha1 to promote invasion of human neuroblastoma cells.
Tanaka N; Fukuzawa M
Int J Oncol; 2008 Oct; 33(4):815-21. PubMed ID: 18813796
[TBL] [Abstract][Full Text] [Related]
26. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.
Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R
Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
28. New CD44 splice variants associated with human breast cancers.
Iida N; Bourguignon LY
J Cell Physiol; 1995 Jan; 162(1):127-33. PubMed ID: 7529235
[TBL] [Abstract][Full Text] [Related]
29. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas.
Terpe HJ; Koopmann R; Imhof BA; Günthert U
J Pathol; 1994 Oct; 174(2):89-100. PubMed ID: 7525912
[TBL] [Abstract][Full Text] [Related]
30. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.
Lokeshwar BL; Lokeshwar VB; Block NL
Anticancer Res; 1995; 15(4):1191-8. PubMed ID: 7544562
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
32. MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.
Spitz R; Hero B; Skowron M; Ernestus K; Berthold F
Eur J Cancer; 2004 Dec; 40(18):2753-9. PubMed ID: 15571958
[TBL] [Abstract][Full Text] [Related]
33. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
[TBL] [Abstract][Full Text] [Related]
34. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
[TBL] [Abstract][Full Text] [Related]
35. CD44 isoforms in metastatic cancer.
Ponta H; Sleeman J; Dall P; Moll J; Sherman L; Herrlich P
Invasion Metastasis; 1994-1995; 14(1-6):82-6. PubMed ID: 7544777
[TBL] [Abstract][Full Text] [Related]
36. [Increased expression of the MYCN oncogene in human neuroblastoma cells and possible, new therapeutic approaches].
Schweigerer L; Fotsis T
Klin Padiatr; 1991; 203(4):319-22. PubMed ID: 1942938
[TBL] [Abstract][Full Text] [Related]
37. MYCN expression in human rhabdomyosarcoma cell lines and tumour samples.
Toffolatti L; Frascella E; Ninfo V; Gambini C; Forni M; Carli M; Rosolen A
J Pathol; 2002 Apr; 196(4):450-8. PubMed ID: 11920742
[TBL] [Abstract][Full Text] [Related]
38. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
[TBL] [Abstract][Full Text] [Related]
39. Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction.
Crabbe DC; Peters J; Seeger RC
Diagn Mol Pathol; 1992 Dec; 1(4):229-34. PubMed ID: 1342970
[TBL] [Abstract][Full Text] [Related]
40. Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.
Nagasaka S; Tanabe KK; Bruner JM; Saya H; Sawaya RE; Morrison RS
J Neurosurg; 1995 May; 82(5):858-63. PubMed ID: 7536236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
